Showing results (21-30 of 11,359) with videos related to
Sort By:
Pageof 1,136
European Journal of Immunology|August 7, 2012
IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cellsZuoan Yi, Li Li, Alaina Garland, et al.Clinical Medicine & Research|September 15, 2005
Immunoregulation of dendritic cellsMark A Wallet, Pradip Sen, Roland TischDiabetes|July 26, 2013
β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD miceMark C Johnson, Alaina L Garland, Sarah C Nicolson, et al.Diabetes|July 4, 2012
Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodiesZuoan Yi, Ramiro Diz, Aaron J Martin, et al.Advanced Materials (Deerfield Beach, Fla.)|November 14, 2021
Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune EncephalomyelitisKin Man Au, Roland Tisch, Andrew Z WangACS Nano|November 29, 2021
In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes MellitusKin Man Au, Roland Tisch, Andrew Z WangJournal of Immunology (Baltimore, Md. : 1950)|November 8, 2013
Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent mannerQiuming He, Y Maurice Morillon, Nicholas A Spidale, et al.JCI Insight|July 27, 2021
Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cellsMatthew Clark, Charles J Kroger, Qi Ke, et al.European Journal of Immunology|July 6, 2006
Lymphopenia-driven CD8(+) T cells are resistant to antigen-induced tolerance in NOD.scid miceBrian Long, Carmen P Wong, Yaming Wang, et al.JCI Insight|October 26, 2016
Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cuesAaron J Martin, Matthew Clark, Gregory Gojanovich, et al.Pageof 1,136